description

OxyContin maker Purdue Pharma reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its settlement offer in bankruptcy proceedings starting as soon as next week, people familiar with the matter said. Jillian Kitchener reports.

general info

  • Uploaded    09/11/2019
  • Business & Finance
  • U.S. retail sales rise at slower pace
  • Time to buy Bitcoin: ex-Prudential CEO George Ball
  • Angry Birds maker happy at profit boost
  • Google stops responding to data requests from HK govt
  • European vacations just got more complicated
  • S&P ends almost flat
  • Euro zone trade surplus surges as imports drop
  • ¿Miente Miguel Torruco por crisis en el turismo Mexicano?
  • U.S. weekly jobless claims fall below 1 million